PHARMA COMMERCE MAGAZINE – There’s no question that the Physicians Sunshine Act—that part of Obamacare that mandates the reporting of payments and contributions of “transfers of value” to healthcare providers (HCPs) by the life sciences industry—has had a major impact on the business of providing HCP identifications, locations and affiliations. These “master data files” have been a steady business for years for the American Medical Assn. and a host of private companies. The Sunshine Act mandates public disclosure of industry payments, aggregated by HCP over the course of a year; at presstime, the first national, industry-wide disclosure was to occur around Sept. 30—but if AMA and others have their way, could be delayed to March 2015.
Read the full article at Pharmaceutical Commerce